Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completion fkansteiner Tue, 01/25/2022 – 10:56

Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use aliu Tue, 01/25/2022 […]

There may be more to the situation than can be shared with youNicola Brown, human resources and employment […]

In their trial of a programme to prevent falls in older people, Logan and colleagues show that training […]

A moderate amount of a peptide-enhanced cancer drug goes a long way in treating breast cancers that metastasize […]

At the time of writing (24 January 2022), unvaccinated NHS workers in England have only until 3 February […]

It’s often too much for parents to absorb, especially when they’re sleep deprived and stressed. A smartphone app […]

By adapting techniques from the domain of artificial intelligence, such as deep learning, cognitive scientists from Osnabrück will […]

A problem with the reference list in this article by Richard Powell and colleagues (BMJ 2022;376:e065574; doi:10.1136/bmj-2021-065574) led […]

The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to […]